{"nctId":"NCT00224133","briefTitle":"The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months","startDateStruct":{"date":"2005-09"},"conditions":["Benign Prostatic Hyperplasia"],"count":661,"armGroups":[{"label":"Silodosin","type":"EXPERIMENTAL","interventionNames":["Drug: Silodosin"]}],"interventions":[{"name":"Silodosin","otherNames":["Rapaflo"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Males in good general health and at least 50 years of age, who have completed SI04009 or SI04010.\n\nExclusion Criteria:\n\n* Medical conditions that would confound the efficacy evaluation.\n* Medical conditions in which it would be unsafe to use an alpha-blocker.\n* The use of concomitant drugs that would confound the efficacy evaluation.\n* The use of concomitant drugs that would be unsafe with this alpha-blocker.","healthyVolunteers":false,"sex":"MALE","minimumAge":"50 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Adverse Events","description":"All reported adverse events were recorded. Clinically significant abnormal laboratory values or other clinical findings upon examination were also recorded as adverse events.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"431","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"188","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"29","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"86","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"54","spread":null}]}]}]},{"type":"SECONDARY","title":"International Prostate Symptom Score (IPSS)","description":"The IPSS is a symptom severity scale from 0 to 35 that is derived from a 7 item questionnaire. 0 indicates no symptoms and 35 indicates most severe symptoms.","classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":29,"n":661},"commonTop":["Retrograde ejaculation"]}}}